Exchange: NASDAQ·Updated 03:11 PM EDT
CGEM logo

CGEM Cullinan Oncology Inc

$21.87
$0.17
(0.78%)
Today
Reported EarningsAug 6
Mkt Cap$1.4B
Vol276,872.00

About CGEM

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
31

Bearish Sentiment

How do you feel about CGEM?

Advertisement|Remove ads.